Inventor · disambiguated record
Kevin James Doyle
Also filed as: DOYLE KEVIN · DOYLE KEVIN J · DOYLE KEVIN JAMES
26 granted patents·20 pending applications·288 citations·filing 2000–2024
97Inventor score
Top patents by PatentIndex Score
46 records- 0198US12054465B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Granted Aug 6, 2024·3 cites·21 claims
- 0298US11814359B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Nov 14, 2023·4 cites·21 claims
- 0398US11773069B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Oct 3, 2023·6 cites·23 claims
- 0498US11680049B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 20, 2023·5 cites·14 claims
- 0598US11117874B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2020·Granted Sep 14, 2021·15 cites·60 claims
- 0698US10669245B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2019·Granted Jun 2, 2020·16 cites·16 claims
- 0797US11673871B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·20 claims
- 0897US11673872B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·14 claims
- 0997US11667615B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·5 cites·15 claims
- 1097US11655222B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1197US11655221B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·22 claims
- 1297US11655223B2Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·21 claims
- 1397US11655224B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1497US10287258B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2017·Granted May 14, 2019·18 cites·6 claims
- 1597US9522894B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2015·Granted Dec 20, 2016·25 cites·8 claims
- 1691US2024336582A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1790US8236838B2Compounds, compositions and methods comprising isoxazole derivativesJONES GRAHAM PETER·Filed 2009·Granted Aug 7, 2012·18 cites·40 claims
- 1890US6297238B1Therapeutic agentsBASF AG·Filed 2000·Granted Oct 2, 2001·65 cites·42 claims
- 1988US8207205B2Compounds, compositions and methods comprising oxadiazole derivativesJONES GRAHAM PETER·Filed 2009·Granted Jun 26, 2012·12 cites·69 claims
- 2087US2023250071A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 2185US6462036B1Tricyclic pyrazole derivativesBASF AG·Filed 2000·Granted Oct 8, 2002·38 cites·55 claims
- 2284US8796321B2Compounds, compositions and methods comprising oxadiazole derivativesJONES GRAHAM PETER·Filed 2012·Granted Aug 5, 2014·6 cites·24 claims
- 2382US6949563B2(2-carboxamido)(3-amino)thiophene compoundsWYNNE GRAHAM MICHAEL·Filed 2004·Granted Sep 27, 2005·19 cites·16 claims
- 2464US2025282728A1Nitrogen comprising heterocyclic derivatives for the treatment of disorders associated with gpr55 receptorCEREVANCE INC·Filed 2023·Application pending·0 cites
- 2563US8343976B2Compounds, compositions and methods comprising pyrazole derivativesINST ONEWORLD HEALTH·Filed 2010·Granted Jan 1, 2013·1 cites·13 claims
- 2662US6900216B2Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agentsKNOLL GMBH·Filed 2001·Granted May 31, 2005·2 cites·29 claims
- 2761US10793559B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 6, 2020·0 cites·3 claims
- 2861US2025019369A1N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as CD38 inhibitorsCEREVANCE INC·Filed 2022·Application pending·0 cites
- 2958US2024158385A1Novel compoundsCEREVANCE INC·Filed 2022·Application pending·0 cites
- 3056US2009318429A1Compounds, Compositions and Methods Comprising Heteroaromatic DerivativesINST ONEWORLD HEALTH·Filed 2009·Application pending·0 cites
- 3153US10457674B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Oct 29, 2019·0 cites·9 claims
- 3251US2009270398A1Compounds, Compositions and Methods Comprising Pyridazine DerivativesINST ONEWORLD HEALTH·Filed 2009·Application pending·0 cites
- 3351US2011237528A1Compositions and methods comprising imidazole and triazole derivativesINST ONEWORLD HEALTH·Filed 2009·Application pending·0 cites
- 3450US2010099677A1Compounds, Compositions and Methods Comprising Thiazole DerivativesINST ONEWORLD HEALTH·Filed 2009·Application pending·0 cites
- 3550US2009264481A1Compounds, Compositions and Methods Comprising Oxadiazole DerivativesINST ONEWORLD HEALTH·Filed 2009·Application pending·0 cites
- 3649US8283351B2Cyclic and acyclic hydrazine derivatives compositions including them and uses thereofRUSSELL MICHAEL GEOFFREY NEIL·Filed 2008·Granted Oct 9, 2012·0 cites·5 claims
- 3749US2009264471A1Compounds, Compositions and Methods Comprising Triazole DerivativesINST ONEWORLD HEALTH·Filed 2009·Application pending·0 cites
- 3849US2013217722A1Novel compound useful for the treatment of degenerative and inflammatory diseasesMENET CHRISTEL JEANNE MARIE·Filed 2013·Application pending·0 cites
- 3947US2009264433A1Compounds, Compositions and Methods Comprising Triazine DerivativesINST ONEWORLD HEALTH·Filed 2009·Application pending·0 cites
- 4047US2022306640A1Hydantoin derivativeONO PHARMACEUTICAL CO·Filed 2020·Application pending·0 cites
- 4146US2010144733A1Compounds, compositions and methods comprising heteroaromatic derivativesINST ONEWORLD HEALTH·Filed 2009·Application pending·0 cites
- 4246US2013217664A1Novel compounds useful for the treatment of degenerative and inflammatory diseasesMENET CHRISTEL JEANNE MARIE·Filed 2013·Application pending·0 cites
- 4334US2010267725A1Compounds, Compositions and Methods Comprising 4N-Substituted Triazole DerivativesINST ONEWORLD HEALTH·Filed 2010·Application pending·0 cites
- 4433US2012129858A1Compounds, compositions and methods comprising pyridazine sulfonamide derivativesPENROSE STEPHEN DAVID·Filed 2010·Application pending·0 cites
- 4532US2010267706A1Compounds, Compositions and Methods Comprising Pyridazine DerivativesINST ONEWORLD HEALTH·Filed 2010·Application pending·0 cites
- 4629US2012136003A1Compounds, compositions and methods comprising 1,3,4-oxadiazole derivativesRUSSELL MICHAEL GEOFFREY NEIL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin James Doyle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →